Concepedia

Szabolcs Ottó

SO

Statistics

Publications

10

Citations

386

H-Index

10

Active since

1993

Affiliations

National Institute of Oncology(Current)

Szabolcs Ottó is an author at National Institute of Oncology specializing in oncology, medicine, and malignant neoplasms.

Publications per year

1993–2017

10

Publications

10

Deletions removing the last exon of<i>TACSTD1</i>constitute a distinct class of mutations predisposing to Lynch syndrome

Marietta Eva Kovacs, J. Papp, Zoltán Szentirmay et al. · Human Mutation · 2009 · 169 citations

Life Sciences, Genetics, Oncology +17

SHMT1 1420 and MTHFR 677 variants are associated with rectal but not colon cancer

Viktor Komlósi, Erika Hitre, Éva Pap et al. · BMC Cancer · 2010 · 49 citations · Full text

Medicine, Genetics, Molecular Genetics +15

Comparison of prognostic significance of serum 5-S-Cysteinyldopa, LDH and S-100B protein in Stage III–IV malignant melanoma

Teodóra Bánfalvi, M. Boldizsár, M. Gergye et al. · Pathology & Oncology Research · 2002 · 41 citations

Medicine, Oncology, Pathology +13

A rákmorbiditás és -mortalitás jelenlegi helyzete a Nemzeti Rákregiszter tükrében

Miklós Kásler, Szabolcs Ottó, István Kenessey · Orvosi Hetilap · 2017 · 30 citations

Medicine, Oncology, Cancer Epidemiology +16

[Cancer mortality and incidence in Hungary in relation to international data].

Szabolcs Ottó, Miklós Kásler · PubMed · 2002 · 20 citations

Medicine, Oncology, Cancer Epidemiology +16

1–5 of 10